Gill Duchesne

Adjuvant radiotherapy versus early salvage radiotherapy following radical prostatectomy (TROG 08.03/ANZUP RAVES): a randomised, controlled, phase 3, non-inferiority trial

Andrew Kneebone, Carol Fraser-Browne, Gillian M Duchesne, Richard Fisher, Mark Frydenberg, Alan Herschtal, Scott G Williams, Chris Brown, Warick Delprado, Annette Haworth, David J Joseph, Jarad M Martin, John HL Matthews, Jeremy L Millar, Mark Sidhom, Nigel Spry, Colin I Tang, Sandra Turner, Kirsty L Wiltshire, Henry H Woo, et al.

Journal article  |  2020  |  The Lancet Oncology

Background: Adjuvant radiotherapy has been shown to halve the risk of biochemical progression for patients with high-risk disease ..

Perineural invasion by prostate adenocarcinoma in needle biopsies predicts bone metastasis: Ten year data from the TROG 03.04 RADAR Trial

Brett Delahunt, Judith D Murray, Allison Steigler, Chris Atkinson, David Christie, Gillian Duchesne, Lars Egevad, David Joseph, John Matthews, Christopher Oldmeadow, Hemamali Samaratunga, Nigel A Spry, John R Srigley, Hubert Hondermarck, James W Denham

Journal article  |  2020  |  Histopathology

AIMS: Perineural invasion (PNI) by prostatic adenocarcinoma is debated as a prognostic parameter. This study investigates the prog..

Radiation Dose Escalation or Longer Androgen Suppression to Prevent Distant Progression in Men With Locally Advanced Prostate Cancer: 10-Year Data From the TROG 03.04 RADAR Trial

David Joseph, James W Denham, Allison Steigler, David S Lamb, Nigel A Spry, John Stanley, Tom Shannon, Gillian Duchesne, Chris Atkinson, John HL Matthews, Sandra Turner, Lizbeth Kenny, David Christie, Keen-Hun Tai, Nirdosh Kumar Gogna, Rachel Kearvell, Judy Murray, Martin A Ebert, Annette Haworth, Brett Delahunt, et al.

Journal article  |  2020  |  International Journal of Radiation Oncology*Biology*Physics

Is adjuvant radiotherapy now history? Implications of the RAVES and RADICALS trial on current practice

M Pearse, A Kneebone, C Fraser-Browne, G Duchesne, A Herschtal, M Frydenberg, S Williams, D Fisher, J Tierney, C Vale, C Adrian, C Parker, M Parmar, M Sydes, S Chabaud, P Richaud, P Sargos

Conference Proceedings  |  2020  |  BJU INTERNATIONAL

A Phase III Multi-Centre Randomised Trial comparing adjuvant versus early salvage Radiotherapy following a Radical Prostatectomy: Results of the TROG 08.03 and ANZUP "RAVES" Trial

A Kneebone, C Fraser-Browne, W Delprado, G Duchesne, R Fisher, M Frydenberg, A Haworth, A Herschtal, DJ Joseph, TS Lim, JM Martin, JL Millar, M Sidhom, N Spry, CI Tang, S Turner, SG Williams, KL Wiltshire, H Woo, M Pearse

Conference Proceedings  |  2019  |  International Journal of Radiation Oncology • Biology • Physics

Effective and well tolerated: where do these drugs fit now?

Gillian M Duchesne

Journal article  |  2019  |  The Lancet Oncology

Short-term androgen suppression and radiotherapy versus intermediate-term androgen suppression and radiotherapy, with or without zoledronic acid, in men with locally advanced prostate cancer (TROG 03.04 RADAR): 10-year results from a randomised, phase 3, factorial trial

James W Denham, David Joseph, David S Lamb, Nigel A Spry, Gillian Duchesne, John Matthews, Chris Atkinson, Keen-Hun Tai, David Christie, Lizbeth Kenny, Sandra Turner, Nirdosh Kumar Gogna, Terry Diamond, Brett Delahunt, Chris Oldmeadow, John Attia, Allison Steigler

Journal article  |  2019  |  The Lancet Oncology

Extracting tumour prognostic factors from a diverse electronic record dataset in genito-urinary oncology

Richard C Khor, Anthony Nguyen, John O'Dwyer, Gargi Kothari, Joseph Sia, David Chang, Sweet Ping Ng, Gillian M Duchesne, Farshad Foroudi

Journal article  |  2019  |  International Journal of Medical Informatics

Timing of Androgen Deprivation Therapy for Prostate Cancer Patients after Radiation: Planned Combined Analysis of Two Randomized Phase 3 Trials

DA Loblaw, J Bassett, C D'Este, G Pond, P Cheung, M Frydenberg, MT King, H Lukka, S Malone, JL Millar, RL Milne, T Pickles, R Smith, MR Stockler, S Turner, KH Tai, H Woo, G Duchesne

Conference Proceedings  |  2018  |  International Journal of Radiation Oncology*Biology*Physics

Trans Tasman Radiation Oncology Group Cancer Research: Phase III - Muscle Invasive Bladder Cancer trial (TROG 02.03): A moral dilemma

Nirdosh K Gogna, Gillian Duchesne, Peter O'Brien, Nigel Spry, Sandra Turner, John Matthews, Martin Borg, Kathryn Bauman, Madeleine King, Elizabeth Burmeister

Journal article  |  2018  |  Journal of Medical Imaging and Radiation Oncology